Skip to main content
INVAMED
HomeINVAblogComparing Extended external monitoring and Short in-clinic ECG
Digital Health & Remote MonitoringFebruary 3, 2025INVAMED Medical Affairs

Comparing Extended external monitoring and Short in-clinic ECG

Extended external monitoring vs Short in-clinic ECG: a balanced, educational comparison of how each works, their trade-offs, and how INVAMED supports both…

This article compares two approaches side by side to clarify how they differ in principle and practice. Extended wear over days to weeks is intended to increase the chance of capturing infrequent arrhythmias compared with very short recordings. As a medical device manufacturer, INVAMED develops technologies in this area; the information here is educational and not medical advice.

Background: Remote Cardiac Rhythm Monitoring for Arrhythmias

Mobile cardiac telemetry (MCT), sometimes abbreviated MCOT, is a category of remote monitoring that can transmit rhythm data, often with the ability to flag events for review. It is used to help detect and characterize arrhythmias such as atrial fibrillation (AFib) and ventricular tachycardia that may occur intermittently and be missed by a brief in-clinic test. Remote cardiac monitoring uses wearable or connected devices to record a patient's heart rhythm outside the hospital, sending the data for review.

Extended external monitoring vs Short in-clinic ECG: Key Differences

A short in-clinic ECG captures only a brief snapshot of the heart rhythm at the moment of the test. Extended external monitoring records over days to weeks, improving the chance of documenting intermittent arrhythmias. RhythmTrack supports typical wear periods of 7 to 14 days or more to widen the observation window, per INVAMED. Which approach is used depends on the clinical question and is decided by the clinician.

How INVAMED Supports Both Approaches

INVAMED describes RhythmTrack in terms of how it is worn, how long it records, how data reaches clinicians, and how arrhythmias are classified and reported. INVAMED offers RhythmTrack Mobile Cardiac Telemetry Monitoring for continuous out-of-hospital detection and reporting of cardiac arrhythmias. The solution uses cellular or Wi-Fi connectivity with secure cloud streaming, plus AI-enhanced arrhythmia classification and auto-report generation, per INVAMED.

Key Considerations

  • Descriptions of features and wear periods reflect INVAMED's product specifications rather than a diagnostic promise for any patient.
  • Connectivity and secure cloud streaming underpin remote review, and data-handling practices should meet applicable requirements.
  • RhythmTrack is intended for use within a clinician-directed monitoring pathway and per its documentation and local approvals.

Frequently Asked Questions

Does RhythmTrack diagnose arrhythmias by itself?

It is designed to record and help classify rhythm data to support clinical review; interpretation and any diagnosis remain with the reviewing clinician.

How long can RhythmTrack be worn?

INVAMED describes RhythmTrack as supporting typical wear periods of 7 to 14 days or more, with the exact duration set by the ordering clinician.

What is the INVAMED remote cardiac monitor called?

INVAMED's mobile cardiac telemetry solution is RhythmTrack Mobile Cardiac Telemetry Monitoring, intended for out-of-hospital detection and reporting of arrhythmias.

About INVAMED

Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.

Clinical and Technical Context

Extended wear over days to weeks is intended to increase the chance of capturing infrequent arrhythmias compared with very short recordings. Whether AFib is present and what it means for a patient is determined by the interpreting clinician. INVAMED's RhythmTrack Mobile Cardiac Telemetry Monitoring is positioned within this remote monitoring category for out-of-hospital rhythm detection and reporting. The role of remote monitoring in a care plan is decided by the treating clinician. It is used to help detect and characterize arrhythmias such as atrial fibrillation (AFib) and ventricular tachycardia that may occur intermittently and be missed by a brief in-clinic test. RhythmTrack is offered with discreet patch or belt wear depending on the model, per INVAMED's description. Connectivity and secure cloud streaming underpin remote review, and data-handling practices should meet applicable requirements. AI-enhanced classification is intended to support clinician review, which remains the basis for interpretation and any decisions.

Related on INVAMED

Important Disclaimer

The information here is provided for educational purposes and to describe device technology; it is not a substitute for professional medical advice, diagnosis, or treatment. Only a licensed healthcare provider can determine whether a given procedure or device is appropriate for a specific patient. INVAMED products are restricted to use by qualified professionals following the official IFU. Regulatory clearance and labeling differ between regions, and not all products or indications are available in every market.

Reviewed by the INVAMED Medical Affairs team. Content is educational and technical in nature.

Reviewed by: INVAMED Medical Affairs

This content is prepared for educational purposes for healthcare professionals and does not constitute medical advice. Always consult clinical guidelines and product instructions for use.

Extended external monitoring vs Short in-clinic ECGremote cardiac monitoringmobile cardiac telemetry (MCT/MCOT)Holter monitorhow it workswear time (24h/48h/14 day/30 day)diagnostic yield